BHVN vs SEPN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
BHVN · Biohaven$14.48 ▲ 4.17%
SEPN · Septerna$48.85 ▲ 3.17%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- BHVN +85.9%
- SEPN +169.9%
Head to head
| Metric | BHVN | SEPN |
|---|---|---|
| Price | $14.48 | $48.85 |
| Change today | ▲ 4.17% | ▲ 3.17% |
| Market cap | $2.19B | $2.28B |
| Return, 3 months | -0.4% | +25.7% |
| Return, year to date | +28.3% | +75.2% |
| Return, 1 year | +75.3% | +163.9% |
| P/E (TTM) | – | – |
| P/B | -22.3 | 5.9 |
| P/E percentile vs own 5y | 44th | 4th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | +22,375.6% |
| Net profit growth (YoY) | +25.5% | +47.5% |
| Gross margin | – | – |
| Operating margin | – | -56.7% |
| Net margin | – | -24.5% |
| Return on equity | – | -6.3% |
| Analyst target vs. price | +95.4% | +8.2% |
| Analyst buy share | 73% | 100% |
| RSI (14) | 53 | 73 |
| 30-day volatility | 92.2% | 54.3% |
| Max drawdown, 1 year | -57.0% | -26.0% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- SEPN is the largest of the group by market value.
- SEPN has returned the most over the past year.
- SEPN has been the calmest stock over the last 30 days.